Inhibrx Biosciences IncNASDAQ:INBX
- LAST PRICE12.8800
- TODAY'S CHANGE (%)-0.1000 (-0.7704%)
- Bid / Lots12.7000/ 8
- Ask / Lots13.7500/ 1
- Open / Previous Close13.0100 / 12.9800
- Day Range
- 52 Week Range
- Volume49,836
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INBX |
|---|---|---|
| 12:09 ET | 300 | 12.9499 |
| 12:18 ET | 100 | 12.93 |
| 12:20 ET | 300 | 12.955 |
| 12:25 ET | 500 | 12.92 |
| 12:34 ET | 100 | 12.92 |
| 12:36 ET | 400 | 12.91 |
| 12:41 ET | 200 | 12.92 |
| 12:43 ET | 800 | 12.93 |
| 12:45 ET | 200 | 12.95 |
| 12:52 ET | 500 | 12.925 |
| 12:54 ET | 200 | 12.94 |
| 12:56 ET | 100 | 12.98 |
| 12:57 ET | 200 | 13.005 |
| 01:01 ET | 204 | 12.97 |
| 01:03 ET | 584 | 12.94 |
| 01:15 ET | 100 | 12.9 |
| 01:21 ET | 981 | 12.91 |
| 01:24 ET | 176 | 12.91 |
| 01:26 ET | 100 | 12.9 |
| 01:35 ET | 338 | 12.89 |
| 01:46 ET | 100 | 12.9 |
| 01:53 ET | 100 | 12.9 |
| 02:02 ET | 900 | 12.92 |
| 02:04 ET | 100 | 12.92 |
| 02:06 ET | 472 | 12.9 |
| 02:08 ET | 100 | 12.88 |
| 02:09 ET | 101 | 12.9 |
| 02:18 ET | 250 | 12.89 |
| 02:22 ET | 200 | 12.89 |
| 02:24 ET | 400 | 12.865 |
| 02:26 ET | 204 | 12.89 |
| 02:29 ET | 200 | 12.88 |
| 02:31 ET | 100 | 12.865 |
| 02:33 ET | 100 | 12.88 |
| 02:38 ET | 100 | 12.88 |
| 02:40 ET | 100 | 12.88 |
| 02:42 ET | 300 | 12.88 |
| 02:47 ET | 100 | 12.885 |
| 02:54 ET | 200 | 12.87 |
| 03:02 ET | 300 | 12.87 |
| 03:12 ET | 400 | 12.87 |
| 03:16 ET | 200 | 12.92 |
| 03:18 ET | 100 | 12.92 |
| 03:21 ET | 100 | 12.92 |
| 03:27 ET | 650 | 12.95 |
| 03:34 ET | 100 | 12.925 |
| 03:38 ET | 100 | 12.88 |
| 03:43 ET | 600 | 12.87 |
| 03:45 ET | 400 | 12.9 |
| 03:48 ET | 200 | 12.875 |
| 03:54 ET | 1004 | 12.915 |
| 03:56 ET | 767 | 12.89 |
| 03:57 ET | 900 | 12.87 |
| 03:59 ET | 1100 | 12.88 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Inhibrx Biosciences Inc | 201.4M | -2.4x | --- |
XBiotech Inc | 200.4M | -5.9x | --- |
Trevi Therapeutics Inc | 200.0M | -8.2x | --- |
Candel Therapeutics Inc | 195.5M | -4.7x | --- |
Immutep Ltd | 288.5M | -7.4x | --- |
Ventyx Biosciences Inc | 208.7M | -0.8x | --- |
Company Information
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. The Company’s clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106. INBRX-109 is a tetravalent agonist of death receptor 5 (DR5) that is designed with its proprietary single domain antibody, or sdAb, platform to drive cancer-selective programmed cell death and to maximize potency while minimizing on-target liver toxicity arising from hepatocyte apoptosis. INBRX-106 is a hexavalent OX40 agonist, being investigated as a single agent and in combination with Keytruda, a PD-1 blocking checkpoint inhibitor, in patients with locally advanced or metastatic solid tumors. INBRX-106 is a precisely engineered hexavalent sdAb-based therapeutic candidate targeting OX40, designed to be an optimized agonist of this co-stimulatory receptor.
Contact Information
- Headquarters
- 11025 N. Torrey Pines Road, Suite 140LA JOLLA, CA, United States 92037
- Phone
- 858-795-4220
- Fax
- 302-636-5454
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $201.4M |
|---|---|
Revenue (TTM) | $1.8M |
Shares Outstanding | 14.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-5.35 |
Book Value | $0.92 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 112.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -13,980.93% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
